Objective Neural stem cells (NSCs) have been found to play an increasing clinical role in stroke. However, at present, it is not yet possible to noninvasively monitor their differentiation once implanted into the brain.
Introduction
Neural stem cells (NSCs) are gradually emerging as a therapeutic tool with a developing clinical translation. However, in vivo monitoring of transplanted cells remains a major challenge [1] . Tracking of cells by cellular MRI that relies on tagging the cells before injection with MRI contrast agents is feasible and has found specific applications in a clinical setting [2] . Although this approach can indicate the location of transplanted cells using the MRI contrast agent as a surrogate marker of cell location, it is not possible to determine the cells' differentiation status.
NSCs differentiate into neurons, astrocytes, and oligodendrocytes. However, after implantation, a significant proportion of cells also do not express mature phenotypic markers, despite having ceased to proliferate. One potential approach to address this currently unmet monitoring need is to implement 1 H-magnetic resonance spectroscopy. 1 H-high-resolution MRS can determine in vitro a particular metabolic profile of cell extracts [3] and yield a distinction, for instance, between neurons and glia, as well as differentiating them from brain tumor cells [4] . Distinguishing NSCs from brain tumor cells is also potentially an important aspect of monitoring the safety of cell transplantation. Manganas et al. [5] have suggested a specific metabolite marker to identify exogenous or endogenous NSCs (e.g. a peak at 1.28 ppm), which would be desirable, although alternative explanations of this marker have emerged [6] [7] [8] .
To monitor the phenotypic differentiation of NSCs, it is essential to establish the metabolite profile present in these cells while under proliferative, yet undifferentiated conditions, as well as in their postmitotic differentiated state. Jansen et al. [9] , for instance, have profiled changes in mouse embryonic stem (ES) cells during neuralization to NSCs. ES cells were characterized by an overall low Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.neuroreport.com).
level of metabolites with nondetectable glycerophosphocholine (GPC) levels, but a high content of phosphocholine (PC). NSCs were found to show a profile similar to glial cells with higher PC, GPC, and myoinositol (mI). As the metabolite profile is dependent on the developmental stage, as well as its regional source from the brain, it is hence important to clearly define the cellular characteristics of the investigated cells. To our knowledge, this is the first report on the metabolic characterizations of undifferentiated and differentiated human neural stem cells (hNSCs).
Methods

Striatal hNSC line
The c-myc-ER TAM conditionally immortalized striatal hNSC line (STROC05; ReNeuron, Guildford, UK) was described previously by Johansson et al. [10] . In brief, STROC05 cells were isolated from the whole ganglionic eminence of a 12-week-old human fetal brain, expanded on laminin-coated culture dishes, and transfected with the retroviral vector pLNCX-2 (Clontech) encoding the c-myc-ER TAM gene. Transfected cell colonies were isolated following neomycin selection before being expanded into a clonal cell line [11] . To maintain proliferation through the conditional immortalization gene, 4-hydroxy-tamoxifen (4-OHT; 100 nM/ml; Sigma-Aldrich, Gillingham, UK) was added to all undifferentiated media.
Expansion of undifferentiated STROC05 cells
Cells were expanded in culture flasks (Falcon, Oxford, UK) coated with mouse laminin at a concentration of 1 : 100 (mouse, 10 mg/ml; Trevigen, Abingdon, UK) at a seeding density of 2.5 Â 10 6 cells/flask. Every 2 days, cells were passaged at 90% confluency and medium was completely replaced. To stimulate proliferation, basic fibroblast growth factor (10 ng/ml) and epidermal growth factor (20 ng/ml) (Peprotech, Rocky Hill, New Jersey, USA) were added to the media (Supplementary Table 1 , Supplemental digital content 1, http://links.lww.com/WNR/ A258).
Long-term differentiation of hNSCs STROC05 cells differentiate spontaneously into appropriate striatal phenotypes over 3 weeks of differentiation. However, neuronal yield and differentiation into the lateral ganglionic eminence-derived GABAergic output neurons is low. To increase neuronal yield and specifically produce more DARPP-32 cells, purmorphamine was added to the differentiation condition [12] . As described in El-Akabawy et al. [12] , long-term cultures were exposed to purmorphamine for 3 weeks. To ensure a long-term attachment, cells were seeded at a density of 2.5 Â 10 6 cells/flask onto laminin and poly-L-lysine (100 mg/ml; Sigma-Aldrich). Cells were grown to 90% confluency before initiation of the differentiation protocol. For the first week of differentiation, media were identical to those of undifferentiated cells (Supplementary Table 2 , Supplemental digital content 2, http:// links.lww.com/WNR/A259), with the exception of exclusion of basic fibroblast growth factor, epidermal growth factor, and tamoxifen from the media.
Dual-phase extraction
From each culture vessel, 1 ml of the supernatant was stored at -801C. Cells were harvested by incubation with Trypzean EDTA (Sigma-Aldrich) for less than 5 min at 371C, followed by the addition of soybean trypsin inhibitor to inactivate enzymatic activity. After harvesting, cells were centrifuged for 5 min at 1500 rpm, and the cell pellet was resuspended in 1 ml ice-cold PBS. Cells were counted and their viability was assessed using the trypan blue exclusion test. 10 7 cells of each sample were then centrifuged for 5 min at 1500 rpm and the cell pellets were resuspended in 2 ml ice-cold methanol. Then, 2 ml of ice-cold chloroform was added to each tube and vortexed for 30 s, followed by the addition of 2 ml of ice-cold deionized water to each tube, and vortexed again for another 30 s. Samples were centrifuged (41C) at 4600 rpm for 20 min for phase separation. The watermethanol and lipid phases, as well as the protein layer, were separated carefully and kept at -801C. Before storage, the water-methanol layers were pretreated with Chelex 100 (1 mg/ml) to remove divalent ions.
High-resolution 1 H-magnetic resonance spectroscopy
The methanol-water fraction (containing water-soluble metabolites) was freeze-dried and reconstituted in 580 ml deuterated water (D 2 O; Sigma-Aldrich). Twenty microliters of 0.75% sodium 3-trimethylsilyl-2,2,3,3-tetradeuteropropionate (TSP) in D 2 O (Sigma-Aldrich) was added to the samples for chemical shift calibration and quantification. Five hundred microliters of the reconstituted extracts were then placed in 5 mm NMR tubes (Apollo Scientific, Bredbury, UK). Lipid extracts were dried and then reconstituted in 450 ml deuterated chloroform (Sigma-Aldrich) and 150 ml of 0.1% tetramethylsilane in deuterated chloroform (Sigma-Aldrich) was added to the samples for chemical shift calibration and quantification. Media from the cultured cells were also analyzed by 1 H-MRS. Five hundred microliters of the media sample and 50 ml of D 2 O were placed in the NMR tube. Fifty microliters of 0.75% TSP in D 2 O was added to the samples for chemical shift calibration and quantification. Spectral assignments were based on literature values [13, 14] . Metabolite uptake and excretion levels in undifferentiated and differentiated cells were evaluated relative to its own respective starting media. irradiation centered on the water frequency. Spectral processing was carried out using the Topspin-2 software package (Bruker).
Statistical analysis
One-tailed Mann-Whitney U-tests were used to compare data from undifferentiated and differentiated cells. Statistical significance was set at a P value less than 0.05. In vitro cell culture studies consisted of three biological replicates, each consisting of three technical replicates. 1 H-MRS results consisted of four biological replicates with viability measurements as well as passage number recorded for each.
Results
Neuronal differentiation of human striatal neural stem cells hNSCs from the STROC05 cell line were differentiated for 3 weeks by the addition of purmorphamine. In comparison with undifferentiated cells, markers of NSCs, such as nestin, and proliferation, such as Ki67, were significantly downregulated ( Supplementary Fig. 1A were oligodendrocytes (GalC(+)ve cells). Calbindin(+)ve neurons (9.11%) were the most common neuronal phenotype, followed by DARPP-32(+)ve GABAergic output neurons (6.4%) and calretinin(+)ve neurons (6.29%). However, within these differentiated cells, no cells expressed choline acetyl transferase (ChAT), as a marker of cholinergic interneurons, and only a very small number expressed tyrosine hydroxylase (TH) (< 1%), as a marker of dopaminergic cells. The viability of these cells after harvesting was excellent for undifferentiated cells (95%), but decreased slightly for differentiated cells (87%) ( Supplementary Fig. 1B , Supplemental digital content 4, http://links.lww.com/WNR/A261). Differentiated cells were at a slightly later passage number (P28) than undifferentiated cells (P23) ( Supplementary Fig. 1C , Supplemental digital content 4, http://links.lww.com/WNR/ A261). These in vitro conditions therefore enabled the investigation of the metabolites that changed during the differentiation of striatal hNSCs.
Water-soluble metabolites in undifferentiated and differentiated hNSCs
For some metabolites, such as combined PC + GPC and mI, very prominent peaks are evident and changes in these metabolites lead to striking differences in the concentration profile between undifferentiated and differentiated cells ( Supplementary Fig. 2 , Supplemental digital content 5, http://links.lww.com/WNR/A262). Significant decreases in threonine, alanine, glutamate, PC + GPC, mI, uridine triphosphate + uridine diphosphate (UTP + UDP), and ATP + ADP were found in differentiated STROC05 cells when compared with undifferentiated cells ( Table 1 ). The concentration of mI was reduced almost 50-fold in differentiated cells, whereas most other metabolites were reduced between two-and five-fold. Although the concentration of N-acetyl-aspartate (NAA) decreased by 50% during differentiation, this did not reach statistical significance. These differences must be considered together with changes or differences in secreted factors in the culturing media. Resonances from 4-(2-hydroxylethyl)-1piperazine-ethane sulfonic acid (HEPES) were only readily observed in extracts of differentiated cells, resulting from cell uptake from the media, as HEPES was only present in the media of the differentiated cells.
Uptake and excretion of metabolites in the culture media
As metabolite changes can be a consequence of different culture conditions, it is important to establish how the uptake and excretion of metabolites is affected by the cell culture media ( Table 2 ). Significant increases (1.1-3.5fold) in the uptake of leucine, iso-leucine, valine, glutamine, tyrosine, phenylalanine, and glucose were found in differentiated compared with undifferentiated STROC05 cells, which is consistent with these metabolites (except for glutamine) being higher in the differentiated media (1.3-2-fold). In contrast, a decrease in alanine excretion was also observed in differentiated cells.
Lipid metabolites in undifferentiated and differentiated hNSCs
The spectra from the lipid phase of an undifferentiated and a differentiated STROC05 cell extract show subtle but significant changes in the levels of a variety of lipids ( Supplementary Fig. 3 , Supplemental digital content 6, http://links.lww.com/WNR/A263). Specifically, cholesterol and cholesterol ester, the methyl resonance of the fatty acids, the -CH = CH-resonance of the fatty acids, phosphatidylcholine, and plasmalogen were significantly increased in differentiated STROC05 cells (Table 3) . A cholesterol ester signal (CS) at 1.58 ppm as well as unidentified resonances at 2.99, 3.84, 6.44, 6.96, and 7.35 to 8.10 ppm were only observed in differentiated cells. These lipids are specific to differentiated cells as these resonances are not present in the lipid extracts of media from differentiated or undifferentiated STROC05 cells.
Discussion
1 H-MRS enables the detection of metabolites in undifferentiated and differentiated hNSC extracts [15] . Significant decreases in water-soluble metabolites were evident, with mI indicating an almost 50-fold decrease in concentration, whereas most other metabolites (e.g. alanine, glutamate) showed a two to five fold decrease.
Many metabolites in the aqueous phase decreased, whereas lipids increased upon differentiation. Specific metabolite changes, reflecting different biological and biochemical processes (e.g. proliferation), therefore characterize the undifferentiated from the differentiated state of hNSCs.
Profiling the neural stem cell state
NSCs are a fairly homogenous population of cells, with all cells being in a similar proliferative state, and therefore generate proteins and cell organelles for cell division, hence constantly increasing their biochemical composition. Indeed, metabolite concentrations in undifferentiated cells were overall much higher than those in differentiated cells. PC + GPC, for instance, was significantly higher in undifferentiated NSCs, reflecting a higher turnover rate of the cellular membrane, consistent with the higher score of the proliferative marker Ki67.
There was a significant decrease in UTP + UDP and ATP + ADP with unchanged creatine in differentiated cells. This lower energetic demand of differentiated cells is consistent with its nonproliferative state. Higher levels of PC + GPC and ATP could therefore indicate whether transplanted cells are still proliferating or whether they have ceased cell division.
Importantly, NSCs are restricted to become brain cells, but are unspecified in terms of becoming a mature brain cell, that is a neuron, astrocyte, or oligodendrocyte. They therefore share commonalities in their metabolite profile with other proliferative cells, such as ES cells or tumor cells. Choline metabolism, leading to elevated levels of choline-containing metabolites, is known to be a key component or result of the transformation of tumor cells and is upregulated upon immortalization [16] . STROC05 cells, which are conditionally immortalized, do show elevated PC + GPC in their undifferentiated state. Interestingly, Jansen et al. [9] reported the absence of GPC and mI in ES cells and their presence in NSCs, indicating that changes in these two metabolites might indeed be related to the NSCs state. mI is easily identified in undifferentiated NSCs and might putatively serve to distinguish NSCs from ES and differentiated brain cells. Nevertheless, mI is an abundant metabolite in the adult brain and believed to act as an osmolyte while being located in glial cells and to a lesser extent in neurons [17] . This metabolite profile is therefore useful to generally describe the NSC state, but is unlikely to specifically define NSCs per se [18] .
Further caution must be exercised as we have to use different growth media during the last 2 weeks of cell differentiation to ensure the survival and attachment of differentiated cells. Differences in media composition between undifferentiated and differentiated cells could influence metabolism as well as the presence or absence of specific amino acids. Nevertheless, the magnitude of changes observed here, such as a 50-fold decrease in mI, cannot account for the small differences in the concentration of these components in both media.
Cell type-specific metabolites
The differentiation of NSCs into mature brain cells produces a heterogeneous cell population consisting of neurons, astrocytes, and oligodendrocytes. Each cell type has specific biochemical features that are associated with different metabolites [19] . Most commonly in vivo, the presence and the level of NAA expression are considered indicators of neurons [20] . However, despite a 45.7% content of neuronal cells, absolute NAA levels here were not significantly different in differentiated cells when compared with undifferentiated cells. Although primary fetal rat neurons contain NAA in vitro when analyzed using MR spectroscopy [3] , there is also robust evidence indicating that at least immature oligodendrocytes can also contain NAA [21] .
Although the maturation of human neurons is a lengthy process, this is considered less so for astrocytes and oligodendrocytes. Here, we achieved a yield of 29.7% astrocytes and 12.9% oligodendrocytes, amounting to a considerable portion of our cell population. Nevertheless, the mI concentration typically associated with astrocytes [22] decreased with differentiation. Glutamine, the main product of astrocytic metabolism [23] , was also decreased in differentiated compared with undifferentiated cells. Absolute levels of glycine were unchanged after 3 weeks of differentiation, whereas taurine was detected neither in undifferentiated nor in differentiated cells. Taurine is synthesized by astrocytes and accumulates in neurons [24] . It will be important to establish how these levels compare with primary astrocytes derived from an adult brain. In contrast, plasmalogen, a lipid that is enriched in myelin sheets [25] , is increased three-fold, potentially being a marker for oligodendrocytes [26] .
In vivo detection of NSCs and neuronal differentiation
In vitro studies enable the investigation of specific cell types under defined conditions. This information is useful to determine which metabolites could be used in vivo to monitor the differentiation of implanted hNCSs. However, in vivo MR spectroscopy in humans or animals is typically performed at lower field strengths and is subject to susceptibility effects associated with tissue structure, leading to broader peaks and higher levels of noise in spectra. Therefore, only clearly identifiable peaks, such as mI, will be useful markers to distinguish undifferentiated and differentiated cells. The localized injection of NSCs to repair damage in neurological conditions, such as stroke, supplies large quantities (> 400 000) of NSCs into striatal or cortical tissue, constituting a large proportion of an in vivo voxel. 1 H-MRS would therefore potentially enable clinicians to determine how many cells were delivered (on the basis of changes in metabolite levels in mI), but would also provide a means to determine whether most of the cells stopped proliferating.
Conclusion 1 H-MRS readily identifies metabolites, such as PC + GPC, associated with the proliferation of NSCs. A combination of PC + GPC and mI might be useful markers of the NSC state, but comparisons with cells at a similar developmental stage are required to better define whether these changes are specific to NSCs and whether this profile is consistent across NSCs derived from different brain regions. These changes in metabolites may be useful to monitor the differentiation of NSCs after intracerebral implantation.
